Arix Bioscience plc (LSE:ARIX) (“Arix” or the “Company”), a global healthcare and life science company supporting medical innovation, today announces that Chief Investment Officer, Joe Anderson, has been reappointed as Chief Executive Officer and will re-join the Arix Board.
February 20, 2019
· 2 min read